Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Atypical Presentation of Seronegative Autoimmune Encephalitis as Refractory Status Epilepticus: A Case Report
Bayan Alalawi1, Feras Beitar1, Salma Alalawi1
1Department of Internal Medicine, Prince Mohammed Bin Abdulaziz National Guard Hospital, Medina, Saudi Arabia.
Abstract:
BACKGROUND Autoimmune encephalitis (AIE) is considered one of the challenging neurological diseases marked by various neuropsychiatric symptoms. These symptoms can manifest as cognitive deficits, seizures, and status epilepticus. Diagnosis can often be complex due to the diverse clinical presentation and the absence of detectable neuronal autoantibodies. CASE REPORT We report the case a 27-year-old man who presented with generalized tonic-clonic seizures, headache, and fever, initially treated as infectious meningoencephalitis. He was given extensive antiviral and antibiotic treatment, but his condition did not improve and he developed refractory status epilepticus. Further investigations using cerebrospinal fluid analysis revealed no infectious cause. This raised a clinical suspicion of AIE, which yielded the use of the "possible AIE criteria." An initial brain magnetic resonance imaging (MRI) scan revealed asymmetrical bilateral cortical areas of abnormal hyperintensities on T2-weighted images with diffusion restriction involving the temporal, frontal, and parietal lobe. Due to the high suspicion of AIE, corticosteroids and plasmapheresis were initiated, leading to marked clinical improvement and significant seizure control with the resolution of fever. A follow-up MRI 4 weeks later showed a significant decrease in the hyperintensities previously depicted on FLAIR, T2-weighted images, and DWI. CONCLUSIONS The diagnosis of seronegative AIE can be challenging because detectable neuronal autoantibodies can be absent. This emphasizes that early suspicion of AIE and the initiation of empirical immunotherapy are crucial for improving patient outcomes, reducing mortality and long-term complications, even with negative or pending autoantibody testing. Further research is needed to improve diagnostic and therapeutic approaches, particularly in regions where antibody testing is limited.
More Related Videos
26:48Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
05:54Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists